Basics Candel Therapeutics, Inc. Common Stock IPO Date: July 27, 2021 Sector: Healthcare Industry: Biotech Market Cap: $258.53M Activated in VL: True Average Daily Range Avg Daily Range: $0.23 | 5.12% Avg Daily Range (30 D): $0.17 | 3.15% Avg Daily Range (90 D): $0.28 | 4.06% Institutional Daily Volume Avg Daily Volume: .69M Avg Daily Volume (30 D): .84M Avg Daily Volume (90 D): .96M Trade Size Avg Trade Size (Sh.): 171 Avg Trade Size (Sh.) (30 D): 133 Avg Trade Size (Sh.) (90 D): 132 Institutional Trades Total Inst.Trades: 96 Avg Inst. Trade: $1.41M Avg Inst. Trade (30 D): $1.11M Avg Inst. Trade (90 D): $1.31M Avg Inst. Trade Volume: .18M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.01M Avg Closing Trade (30 D): $1.06M Avg Closing Trade (90 D): $1.94M Avg Closing Volume: 275.62K     News Apr 1, 2025 @ 12:01 PM Candel Therapeutics Announces Publication of Phase... Source: N/A Mar 18, 2025 @ 12:00 PM Candel Therapeutics Appoints Renowned Pancreatic C... Source: N/A Dec 12, 2024 @ 9:51 PM Candel Therapeutics Announces $80 Million Proposed... Source: N/A Sep 4, 2024 @ 12:00 PM Milestone Pharmaceuticals Appoints Industry Vetera... Source: N/A Jul 19, 2024 @ 12:41 PM Candel Therapeutics executive sells over $63k in c... Source: Investing.Com Financials   TTM Q1 2025 Q3 2024 Basic EPS $.15 $-.33 Diluted EPS $.13 $-.33 Revenue $ $ M $ M Gross Profit $ $ $ Net Income / Loss $ $ 7.38M $ -10.65M Operating Income / Loss $ $ -8.13M $ -8.76M Cost of Revenue $ $ $ Net Cash Flow $ $ -10.49M $ -4.9M PE Ratio